• New CRISPR/Cas9 license agreement to advance disease model development

Company news

New CRISPR/Cas9 license agreement to advance disease model development

Ricoh Company, Ltd has announced a non-exclusive licensing agreement with ERS Genomics Ltd for access to foundational CRISPR/Cas9 genome editing technology patents in the USA and Japan.

CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise modification of targeted genome sequences. It plays a crucial role in drug discovery and is utilised in various research fields.

In 2022, Ricoh acquired Elixirgen Scientific, Inc, which specialises in rapid and efficient differentiation of human iPS cells and mRNA design, production, and management. Combining these technologies with CRISPR/Cas9, Ricoh aims to enhance the prediction of drug mechanisms for patients with diverse genetic backgrounds and to improve mRNA design speed and efficiency. This integration allows for the creation of reliable disease models, including those for rare diseases, potentially shortening drug development timelines and increasing success rates.

Ricoh is expanding the application of Elixirgen Scientific's technology by utilising its expertise in digital and artificial intelligence technologies. This initiative aims to accelerate personalised medicine, drug discovery research, and regenerative medicine. Ricoh is committed to advancing drug development research through the diverse solutions offered by Elixirgen Scientific.

Summit Pharmaceuticals International Corporation, a subsidiary of Sumitomo Corporation, is the exclusive representative of ERS Genomics in Japan.

More information online


Digital Edition

Lab Asia 32.1 Feb 2025

February 2025

Chromatography Articles - Comparing volumetric and thermal flowmeters for assessing and validating liquid chromatography performance Mass Spectrometry & Spectroscopy Articles - The importa...

View all digital editions

Events

SPS Smart Production Solutions Guangzhou

Feb 25 2025 Guanghzou, China

SmartLab Exchange

Feb 25 2025 Amsterdam, Netherlands

Nepal Lab

Feb 27 2025 Kathmandu, Nepal

PITTCON 2025

Mar 01 2025 Boston, MA, USA

IFPAC 2025

Mar 02 2025 Bethesda, MD, USA

View all events